Skip to content
GTL KOREA
For Technology Owners

For Technology Owners

Protection First. Structure for Commercialization. Connect to Real Demand.

보호 먼저, 구조로 사업화, 실제 수요로 연결합니다.

Technology Without Market Access

Strong technology that never reaches real demand or channels.

Patent Without Strategy

Patents disconnected from a commercialization strategy lose their value.

Weak Evidence Package

Insufficient evidence fails to convince capital and partners.

1 IP-First Discipline
2 Evidence Building
3 Structuring
4 Demand Matching
5 Capital Connect
6 Global Partners

What GTL delivers

IP Protection & Confidentiality Protection before disclosure, with confidentiality discipline.
Stage Diagnosis Diagnose commercialization stage and bottlenecks.
Evidence Structuring Structure reviewable, diligence-ready evidence.
Market Access Connect to real demand and customers.
Global Partners Global strategic partnerships.
Capital Connection Connect to capital and strategic partners.
Commercialization Readiness Journey

From technology ownership to commercialization readiness

We frame the path from owning technology to a market-reviewable position as five public-level stages.

  1. 01

    Deeptech Commercialization

    The starting point: turning research and technology assets into a reviewable commercialization structure.

  2. 02

    Global R&D Linkage

    A public-level view of linkage with global research and technology networks.

  3. 03

    Korea Launch Hub

    Designing a path that uses Korea as a launch hub for Asia market entry.

  4. 04

    Expert Validation

    Structuring technology and commercialization readiness through an expert review lens.

  5. 05

    Market-Entry Readiness

    Reaching the readiness needed for market entry and strategic partnerships.

Who this is for

Which technology owner are you?

The commercialization review path depends on the nature of your assets. Pick the closest fit below to get started.

Companies & Startups

For companies and startups translating their technology and patents into reviewable commercialization structures.

Universities, Labs & TLOs

For universities, research institutes, and technology transfer offices extending research outcomes toward market connection and commercialization.

Global Technology Companies

For overseas technology companies preparing for Korea and Asia market entry and strategic partnerships.

Platform, Software & AI

For teams structuring the commercialization and adoption of platform, software, and AI assets.

Stage Fork

Your review path by investment stage

Stage is determined solely by whether a Series-A investment has been raised — not by revenue, technical validation, or market traction.

Review path · SCIENGeer On-Ramp

Before Series-A

Research outcomes and early-stage companies before Series-A are routed to SCIENGeer for commercialization readiness.

Review path · HQ Deal & Transaction

After Series-A

Technology companies after Series-A are routed to HQ Deal & Transaction for higher-value commercialization review.

Not sure of your stage yet

If your investment stage is not yet confirmed, start with a GTL review.

Request a stage review
Intellectual Capital

A technology owner’s technology and patents are not standalone assets but core components of Intellectual Capital. GTL connects them to intellectual property, PoC, market demand, partners, and capital review to improve commercialization feasibility.

View Intellectual Capital
Secure Intake

Ready to Start Your Journey?

Initial inquiries are received through Secure Intake. A separate NDA may be executed before detailed confidential information is disclosed.

Submit Your Technology

  • Secure Intake Submission
  • Confidential IP Review
  • Structured Evaluation Process
  • Secure Communication Channel
Secure SubmissionIP-First Review
Start a Commercialization or Partnership Discussion

Request a Confidential Briefing

  • Executive-Level Discussion
  • Strategic Partnership Exploration
  • Technology Portfolio Review
  • Custom Engagement Structure
Confidential ReviewExecutive Access
Request a Capital & Strategic Partner Briefing